RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

NARecruitingINTERVENTIONAL
Enrollment

801

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

July 30, 2026

Study Completion Date

March 31, 2031

Conditions
Breast Neoplasm Female
Interventions
PROCEDURE

Core needle biopsy

"1st core needle biopsy for RDA (2 specimens): Time Point: 35 +/-4 days after initiation of chemotherapy.~If no change is made to the therapy, a second biopsy (2 specimens) will be performed at 55 +/- 5 days after therapy initiation.~If there is a change of drugs, the second biopsy (2 specimens) will be performed at \~2-3 weeks after initiation of new drugs; Timing by type of drug schedule 3-weekly: at 16 days +/- 2 days, Bi-weekly: at day of 2nd dose preferably before drug admin., Weekly: at day of 4th dose preferably before drug admin."

Trial Locations (7)

63129

RECRUITING

Siteman Cancer Center, St Louis

Unknown

RECRUITING

Sunnybrook Health Sciences Center, Toronto

RECRUITING

Institut de Cancerologie de Strasbourg, Strasbourg

RECRUITING

Universitätsklinikum Münster, Münster

RECRUITING

SST di Cremona Multidisciplinare di Patologia Mammaria, Italy, Cremona

RECRUITING

NZOZ Neuromed, Lublin

RECRUITING

Hospital U. 12 de Octubre, Madrid

All Listed Sponsors
lead

Rna Diagnostics Inc.

INDUSTRY